-
Mashup Score: 6
A whole food, plant-based diet has shown benefits for patients with chronic kidney disease (CKD).
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Lucia Masarova, MD, on Transfusion-Related Cost Findings From SIMPLIFY-1 | Docwire News - 2 month(s) ago
Dr. Lucia Masarova described data on ruxolitinib versus momelotinib from SIMPLIFY-1 comparing total medical cost and time burden related to outpatient transfusion in myelofibrosis.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
RT @HemeToday: Flashback Friday!! @mdmasarova breaks down the SIMPLIFY-1 study for us. @mdandersonnews @GSKUS https://t.co/ufAoiKs7zT
-
-
Mashup Score: 1Heme Today | Docwire News - 2 month(s) ago
Heme Today covers the latest news and analyses in bleeding, clotting, red blood cell, and iron disorders for hematologists and oncologists focused on bleeding disorders.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
RT @HemeToday: Next month is #BleedingDisordersAwarenessMonth from the @NBD_Foundation. 🩸 Visit https://t.co/3mXmzycevE to catch up on…
-
-
Mashup Score: 0Zahra Pakbaz, MD, Describes the Value of a Dedicated Classical Hematology Clinic | Docwire News - 2 month(s) ago
Dr. Pakbaz, from the University of California Irvine, shared data on the value of a dedicated classical hematology clinic.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
Dr. Pakbaz from the University of California, Irvine, met with Heme Today to discuss challenges faced by adult patients with noncancer blood disorders due to the current lack of dedicated specialists. Watch Now: https://t.co/wU0xKBRTzt https://t.co/LxBKbZpuUS
-
-
Mashup Score: 0VTE in Hemophilia Appears Rare After Total-Joint Replacement Even Without Prophylaxis | Docwire News - 2 month(s) ago
Patients with hemophilia A or B had low rates of symptomatic venous thromboembolism after total-joint replacement despite infrequent usage of thromboprophylaxis
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
Patients with hemophilia A or B had low rates of symptomatic VTE after total-joint replacement despite infrequent usage of thromboprophylaxis. Read More: https://t.co/xUmRWDOABl https://t.co/COnAYA65Bp
-
-
Mashup Score: 2CheckMate 8HW: Nivolumab Plus Ipilimumab Offers Better PFS for mCRC Over Chemotherapy Alone | Docwire News - 3 month(s) ago
At ASCO GI 2024, Dr. Thierry Andre presented the first results of the CheckMate 8HW study on the use of nivolumab plus ipilimumab versus chemotherapy and nivolumab monotherapy.
Source: www.docwirenews.comCategories: Expert PicksTweet-
Earlier today at @ASCO #GI24, Dr. Thierry Andre presented results of the CheckMate 8HW study that demonstrated the benefits of nivolumab plus ipilimumab over chemotherapy alone for #ColorectalCancer. Learn More: https://t.co/P7LPt8t3Ll
-
-
Mashup Score: 1EMERALD-1: Durvalumab Plus Bevacizumab With TACE Versus TACE Monotherapy | Docwire News - 3 month(s) ago
Dr. Riccardo Lencioni presented new data from the EMERALD-1 study on combining TACE plus durvalumab with and without bevacizumab.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
RT @GiOncNow: EMERALD-1 study results are being presented at @ASCO #GI24 now. Read the results: https://t.co/9wdq6lfk7g
-
-
Mashup Score: 2
Dr. Christopher Lieu gives an overview of some of the top presentations and data to look out for at ASCO GI 2024, and discusses the importance of the event.
Source: www.docwirenews.comCategories: Expert PicksTweet-
We spoke with Dr. Christopher Lieu from @CUCancerCenter on the upcoming @ASCO #GI24 conference, including presentations to keep an eye on and the importance of the event for researchers and physicians. Watch now: https://t.co/DgXZEDrOst https://t.co/oExmTNmIOb
-
-
Mashup Score: 2
Dr. Christopher Lieu gives an overview of some of the top presentations and data to look out for at ASCO GI 2024, and discusses the importance of the event.
Source: www.docwirenews.comCategories: Expert PicksTweet-
We spoke with Dr. Christopher Lieu from @CUCancerCenter on the upcoming @ASCO #GI24 conference, including presentations to keep an eye on and the importance of the event for researchers and physicians. Watch now: https://t.co/DgXZEDrOst https://t.co/oExmTNmIOb
-
-
Mashup Score: 9
Drs. Hossein Borghaei and Tony Calles join Dr. Nabhan to dissect cutting-edge data from the ESMO Congress 2023, spotlighting the transformative landscape of lung cancer treatment.
Source: www.docwirenews.comCategories: General Medicine News, Onc News and JournalsTweet-
Dr. @HosseinBorghaei recently joined the Healthcare Unfiltered podcast to discuss pivotal abstracts and cutting-edge data from the ESMO Congress 2023, spotlighting the transformative landscape of lung cancer treatment. Listen here: https://t.co/ITFz3O8KyT
-
Whole Food, Plant-Based Diets for Patients With CKD | Docwire News https://t.co/iG1Q1CKIpC